VigiLanz Corporation  

Minneapolis,  MN 
United States
http://vigilanzcorp.com

• Booth: 2227

VigiLanz transforms the full potential of system-wide clinical data into actionable alerts that empower earlier intervention for optimal outcomes. Our SaaS platform helps you advance pharmacy surveillance, antimicrobial stewardship, opioid stewardship, infection prevention, quality improvement, early sepsis detection, and more.

 Press Releases

• VigiLanz Ranked No. 1 by KLAS Research for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance (Oct 28, 2019)

  MINNEAPOLIS – Jan. 31, 2019 – VigiLanz, a clinical surveillance company, today announced that it has earned 2019 Category Leader designations from KLAS Research for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance.

  This is the second year VigiLanz has earned the No. 1 distinction for multiple categories. The company previously achieved Category Leader status in 2018 for Infection Control and Monitoring and Pharmacy Surveillance. Antimicrobial Stewardship is a new KLAS category for 2019.

  Three VigiLanz products were recognized in the “2019 Best in KLAS: Software and Services” report, released on January 31:

  VigiLanz Dynamic Infection Control Monitor

  Earning a score of 90.6, the Dynamic Infection Control Monitor is a seamless, real-time automated

  monitoring system that works with an organization’s standard EHR system. Its automatic exception-based

  alert system puts all patient records under continuous surveillance to alert decision makers in real time of

  potential infections, drug-bug mismatches, MDROs, isolation candidates, organism clusters, conditions of

  concern and reportable infections. The surveillance is based on a sophisticated set of customizable rule

  engines.

  VigiLanz Dynamic PharmacoVigilance

  Earning a score of 93.0, Dynamic PharmacoVigilance acts as a bridge between a hospital’s pharmacy and

  lab information systems, automating the comparison of patients’ drug usage with lab results, then

  presenting the potential for Adverse Drug Event reduction. Based on the system’s built-in rule sets or

  hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make

  appropriate drug therapy decisions.

  VigiLanz Antimicrobial Stewardship

  Earning a score of 94.6, the Antimicrobial Stewardship product monitors antimicrobial therapy to ensure appropriate use, including unnecessary antibiotic therapy, de-escalation opportunities, positive rapid diagnostic test results, and opportunities for antibiotic “time-outs.” The Antimicrobial Stewardship dashboard shows usage and resistance trends across the organization, is Meaningful Use 3 certified, and provides direct reporting to the Centers for Disease Control’s National Healthcare Safety Network.

  “It’s an honor to be recognized by KLAS as a leader in multiple categories for the second time, validating

  the confidence and trust we know our customers have in our clinical surveillance products,” said VigiLanz

  Chairman and CEO David Goldsteen, MD. “KLAS’ global reputation for accurately and impartially

  measuring vendor performance is an unparalleled channel for customer feedback – something we find

  invaluable to our culture of continued innovation. We look forward to continuing to provide industry-

  leading solutions to hospitals across the country that improve the safety and quality of patient

  outcomes.”

  The KLAS Category Leader designation is awarded to vendors that lead select market segments in which

  at least two products meet a minimum number of KLAS Konfidence reviews. Rankings are based on

  customer surveys of North American healthcare leaders, administrators, clinicians, and others who

  interact with the solutions.

  About VigiLanz

  ###

  About KLAS

  KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and

  payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers

  insights on software, services and medical equipment to deliver timely reports, trending data and

  statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the

  voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more

  about KLAS and the insights we provide, visit www.KLASresearch.com.

  Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS- based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.